Gastrointestinal (GI): NSAIDs that block COX-one activity have correlations with GI issues due to inhibition on the synthesis of gastroprotective agents which include PGE2 and other prostaglandins. This inhibition causes lowered mucin creation by gastric epithelial cells, less bicarbonate secretion, and less epithelial mobile turnover, amongst other steps. This characteristic https://diclofenac-sodium51593.tkzblog.com/29597009/what-does-diclofenac-sodium-mean